Heart Disease Trial, Recruiting (NCT07107568)

Heart Disease Trial, Recruiting NCT07107568 Sponsor: Medical University Innsbruck Condition: Heart Disease

Printed from Voxsanity (voxsanity.com.au) — NCT07107568 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Heart Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who are 18 years of age or older
People who have been diagnosed with severe narrowing of the aortic heart valve and whose doctors have determined that a procedure is needed, based on current European heart guidelines
People who have been assessed as suitable candidates for a type of heart valve procedure called TAVR (a minimally invasive procedure to replace the aortic valve)
People who are willing and able to provide written consent to participate

Who may not be able to join:

People whose heart is in a critical state of failure at the time of presentation, requiring an emergency TAVR procedure
People whose kidneys are functioning at a severely reduced level (confirm with trial site for specific kidney function measurements)
People who have another serious non-heart-related illness, such as cancer, where life expectancy is estimated to be less than one year
People who are pregnant

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Sebastian J Reinstadler, MD, PhD, Medical University Innsbruck

Phone: +43 512 504 25665

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07107568

Sponsor: Medical University Innsbruck

Phase: Not Applicable

Status: Recruiting

Condition: Heart Disease

Trial contact: +43 512 504 25665

More information: https://clinicaltrials.gov/study/NCT07107568

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who are 18 years of age or older
People who have been diagnosed with severe narrowing of the aortic heart valve and whose doctors have determined that a procedure is needed, based on current European heart guidelines
People who have been assessed as suitable candidates for a type of heart valve procedure called TAVR (a minimally invasive procedure to replace the aortic valve)
People who are willing and able to provide written consent to participate

Who may not be able to join:

People whose heart is in a critical state of failure at the time of presentation, requiring an emergency TAVR procedure
People whose kidneys are functioning at a severely reduced level (confirm with trial site for specific kidney function measurements)
People who have another serious non-heart-related illness, such as cancer, where life expectancy is estimated to be less than one year
People who are pregnant

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Medical University Innsbruck

Registry

ClinicalTrials.gov

Start date

14 August 2025

Est. completion

31 December 2029

Where this trial is recruiting

🇦🇹 Austria

Primary endpoints

Major adverse cardiovascular events (MACE) at 12 months

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov